News

Talking With Docs on MSN1h
Blood transfusions in 2021 | Will I need one for my total joint replacement?
CeeDee Lamb takes big hit from sprinting official while WR is in street clothes on the sideline ...
Targeted Oncology2d
Roxadustat Phase 3 Trial for Anemia in Lower-Risk MDS Receives FDA Go-Ahead
Roxadustat advances as a promising oral treatment for anemia in lower-risk myelodysplastic syndromes, targeting high ...
FibroGen stock surges after FDA feedback on roxadustat for MDS anemia
Investing.com -- FibroGen Inc (NASDAQ: FGEN) stock jumped 9.9% following positive feedback from the U.S. Food and Drug Administration supporting the advancement of roxadustat for treating anemia in ...
TMCnet3d
FibroGen Announces Positive Type C Meeting with the FDA for Roxadustat in Patients with Anemia Associated with Lower-Risk Myelodysplastic Syndromes
FibroGen has reached agreement with the FDA on important design elements for a pivotal Phase 3 clinical trial for roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic ...